Clinical heterogeneity in patients with myoclonus associated to COVID-19.
Gary Álvarez BravoLaura Sánchez CireraMònica Angerri NadalLluís Ramió I TorrentàPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
Our 6 cases highlight the heterogeneity of the clinical spectrum of myoclonus associated to COVID-19 (MYaCO). MYaCO pathogenesis is suspected to be due to an immune-mediated para- or post-infectious phenomenon; nevertheless, further research is needed to elucidate this hypothesis.